Session: Where the Bench Meets the Bedside: Laboratory Correlates in Clinical Trials
Hematology Disease Topics & Pathways:
Research, Fundamental Science, clinical trials, Translational Research, CHIP, Clinical Research, Combination therapy, genomics, hematopoiesis, real-world evidence, Therapies, therapy sequence, registries, Biological Processes, molecular biology, pathogenesis
Disclosures: Santini: Geron: Membership on an entity's Board of Directors or advisory committees; Gilead: Membership on an entity's Board of Directors or advisory committees; CTI: Membership on an entity's Board of Directors or advisory committees; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; Otsuka: Membership on an entity's Board of Directors or advisory committees; Servier: Membership on an entity's Board of Directors or advisory committees; BMS: Honoraria, Membership on an entity's Board of Directors or advisory committees; AbbVie: Membership on an entity's Board of Directors or advisory committees; Syros: Membership on an entity's Board of Directors or advisory committees; Janssen: Other: Travel support.
See more of: Spotlight Sessions